The success of the EGFR and VEGFR pathway antagonists in treatment of metastatic NSCLC has important implications for development of novel targeted therapies such as the PKC inhibitors.
EGFR和VEGFR途径拮抗剂在治疗转移性NSCLC中的成功对开发一种新的靶向治疗药物如PKC抑制剂具有重要意义。
The process identified in this study could offer a promising target for the development of new treatments to prevent the further spread of metastatic cancer.
搞清楚这一过程，为我们提供了一个很有用的靶向目标，可以用于开发研制治疗和防止肿瘤进一步扩散的药物和手段。
The process identified in this study could offer a promising target for the development of new treatments to prevent the further spread of metastatic cancer.
搞清楚这一过程，为我们提供了一个很有用的靶向目标，可以用于开发研制治疗和防止肿瘤进一步扩散的药物和手段。
应用推荐